Molecular Diagnosis FCoV Feline Cat Test Kit Giardia Feline Dna Test Kit

Molecular Diagnosis Quantitative Multiple Feline Digestive Pathogens Nuclic Acid detection Kit

Intend for Use:

This kit is suitable for the specific detection of feline parvovirus (FPV), feline coronavirus (FCoV), fetal trichomonas (TF) and giardia (GD) in cat eye, mouth and nose secretions and other samples.

Principle:

Under the action of high-efficiency reverse transcriptase, cDNA strands complementary to RNA template were synthesized with PRIMER as starting point and RNA template as template. Choose cat tiny virus, coronavirus, SAN MAO trichomonas fetus, jia drops of giardia conservative design specific gene probe, the probe can with primer amplification area in the middle of a specific binding DNA template, in the process of PCR extension, the circumscribed Taq polymerase enzymes from the 5 'end of fluorescent groups on the probe will be cut down, make it free in the reaction system, Thus, the 3 '-end quenched group was separated, and the fluorescence was emitted, and the nucleic acids of feline parvovirus, feline coronavirus, fetal trichomonas and giardia were detected by fluorescence PCR instrument in the completely closed reaction system.

Component:

Sample requirements:

1. Sample type
Cat eye, mouth and nose secretion and other samples
2. Sample collection and transportation
Sample collection and transportation shall be carried out in accordance with NY/T 541. Samples shall be transported to the laboratory as soon as possible under refrigerated conditions to avoid repeated freeze-thaw.
3. Sample preservation
It can be stored for 24 hours at 2℃~8℃, and can be stored for a long time at -70℃.

FPV/FCoV PCR Reaction reagent:

Note: "+" means positive, "-" means negative

TF/GD PCR PCR Reaction reagent:

Note: "+" means positive, "-" means negative

Product picture:

Bio key Health is a high-tech enterprise with integrating R&D, production and sales&marketing in Guangzhou. Since 2003. Bio Key was founded by the "Thousand Talents Program" entrepreneurial team and the overseas senior automation equipment development engineer team.

The company's core team has been in the field of IVD research and entrepreneurship for more than 10 years, and has mastered a wealth of molecular diagnostic POCT industrial application technology, SmartTRF immune detection technology, RT qPCR nucleic acid detection technology and independent research and development capabilities of instruments.

It has a number of independent core technologies in the fields of automation engineering, micro-precision manufacturing, immunofluorescence, nucleic acid detection and gene sequencing. Since its establishment, the company has applied for more than 60 patents and currently has 17 authorized patents. The company has two R&D centers for diagnostic reagents and instruments and equipment, totaling more than 500 square meters; it has established more than 2,000 square meters of GMP workshops and equipment production plants; it has SmartTRF new immune detection technology, nucleic acid detection technology (POCT) and three scientific services.